Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Calcium pantothenate Market Price & Analysis > Market Insights - Calcium pantothenate > Calcium pantothenate, the raw material of Xinfa Pharmaceutical, passed the new GMP inspection and can be put on the market
— Share —

Calcium pantothenate, the raw material of Xinfa Pharmaceutical, passed the new GMP inspection and can be put on the market

healthoo 2021-11-17
On November 16, 2021, Xinfa Pharmaceutical Co., Ltd.'s raw material calcium pantothenate (registration number: Y20170001343) successfully passed the new version of GMP compliance inspection and can be put on the market.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.